MFA, especially at the highest dose, reduced cytokine levels (IL-1β, IL-18, and TNF-α) in the early stages of sepsis, favoring a balance of the immune system and of equilibrium of inflammatory components, crucial for the development of a favorable outcome. The gene discussed is IL18; the disease is Sepsis.